(Q37916824)

25 August 2017

Italian guidelines for diagnosis, prevention, and treatment of invasive fungal infections in solid organ transplant recipients (English)

1 reference

invasive fungal infections

25 August 2017

0 references

1 reference

F Pea

10

0 references

author name string

P A Grossi

1

1 reference

25 August 2017

D Dalla Gasperina

2

1 reference

25 August 2017

F Barchiesi

3

1 reference

25 August 2017

G Biancofiore

4

1 reference

25 August 2017

G Carafiello

5

1 reference

25 August 2017

A De Gasperi

6

1 reference

25 August 2017

G Sganga

7

1 reference

25 August 2017

F Menichetti

8

1 reference

25 August 2017

M T Montagna

9

1 reference

25 August 2017

M Venditti

11

1 reference

25 August 2017

P Viale

12

1 reference

25 August 2017

C Viscoli

13

1 reference

25 August 2017

A Nanni Costa

14

1 reference

25 August 2017

language of work or name

English

0 references

publication date

1 July 2011

1 reference

Transplantation Proceedings

25 August 2017

1 reference

25 August 2017

43

1 reference

25 August 2017

6

1 reference

25 August 2017

2463-2471

1 reference

Infection in solid-organ transplant recipients

25 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Introduction: infection in solid organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Fungal infections in solid organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Candida in solid organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Invasive aspergillosis in solid organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Emerging & rare fungal infections in solid organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Fungal infections in lung transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Aspergillus Galactomannan Antigen in the Bronchoalveolar Lavage Fluid for the Diagnosis of Invasive Aspergillosis in Lung Transplant Recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Reappraisal of the serum (1-->3)-beta-D-glucan assay for the diagnosis of invasive fungal infections--a study based on autopsy cases from 6 years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Serologic evidence for reactivation of cryptococcosis in solid-organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Cryptococcosis in solid organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Real-time PCR in clinical microbiology: applications for routine laboratory testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Donor-derived infections in solid organ transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Invasive aspergillosis in transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Imaging features of invasive and noninvasive fungal sinusitis: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Fungal liver infection in immunocompromised patients: depiction with multiphasic contrast-enhanced helical CT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Detection of acute and treated lesions of hepatosplenic candidiasis: comparison of dynamic contrast-enhanced CT and MR imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Hepatosplenic fungal disease: diagnostic accuracy and spectrum of appearances on MR imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Clinical aspects of invasive candidiasis in solid organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Antifungal prophylaxis in liver transplant patients: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Antifungal agents for preventing fungal infections in non-neutropenic critically-ill patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Safety of aerosolized amphotericin B lipid complex in lung transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Comparison of caspofungin and amphotericin B for invasive candidiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Anidulafungin versus fluconazole for invasive candidiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Echinocandins--an advance in the primary treatment of invasive candidiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Plasma levels of voriconazole administered via a nasogastric tube to critically ill patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

A case of Aspergillus mediastinitis after heart transplantation successfully treated with liposomal amphotericin B, caspofungin and voriconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Aspergillus fumigatus empyema, arthritis, and calcaneal osteomyelitis in a lung transplant patient successfully treated with posaconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Native lung pneumonectomy for invasive pulmonary aspergillosis following lung transplantation: a case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Rhino-orbital-cerebral zygomycosis in solid organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Antifungal therapy in invasive fungal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Posaconazole as salvage therapy for zygomycosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Posaconazole mono- or combination therapy for treatment of murine zygomycosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Fusarium infections in immunocompromised patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

10.1016/J.TRANSPROCEED.2011.06.020

7 January 2021

Identifiers

DOI

1 reference

25 August 2017

1 reference